Payload Information
General Information of This Payload
| Payload ID | PAY0RINMR |
|||||
|---|---|---|---|---|---|---|
| Name | 10NH2-11F-Camptothecin |
|||||
| Synonyms |
10NH2-11F-Camptothecin
Click to Show/Hide
|
|||||
| Target | DNA topoisomerase I (TOP1) | |||||
| Structure |
|
|||||
| Formula | C20H16FN3O4 |
|||||
| Isosmiles | CC[C@]1(O)C(C=C2C3=NC4=CC(F)=C(N)C=C4C=C3CN52)=C(COC1=O)C5=O |
|||||
| PubChem CID | ||||||
| InChI |
InChI=1S/C20H16FN3O4/c1-2-20(27)12-5-16-17-10(3-9-4-14(22)13(21)6-15(9)23-17)7-24(16)18(25)11(12)8-28-19(20)26/h3-6,27H,2,7-8,22H2,1H3/t20-/m0/s1
|
|||||
| InChIKey |
DTFQCOHTHXUPMI-FQEVSTJZSA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
381.363 |
Polar area |
107.44 |
||
Complexity |
1231.353615 |
xlogp Value |
1.8009 |
|||
Heavy Count |
28 |
Rot Bonds |
1 |
|||
Hbond acc |
7 |
Hbond Donor |
2 |
|||
The activity data of This Payload
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
38354417 T-DL9 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.51 nM
|
High HER2 expression (HER2 +++) | ||
| Method Description |
A total of 30,000 SK-BR-3 (HER2-high) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 30 nM | Negative HER2 expression (HER2-) | ||
| Method Description |
A total of 10,000 MDA-MB-468 (HER2-negative) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
References